A previously announced public offering has been upsized by OpGen in hopes of raising up to $15.6 million, according to an amended prospectus filed by the company with the SEC. The company intends to float 13.7 million shares of its common stock and warrants to buy over 6.8 million additional shares and estimates net proceeds from the offering to reach $8.5 million.
OpGen looks to raise up to $15.6M in public offering
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.